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INTRODUCTION
Tuberculosis (TB) is the leading cause of mortality and morbidity in developing world. In 2012, 0.5 million new incident cases were reported in Pakistan with an incidence of 231/100,000 population [1] . Pakistan ranks 6 th among 22 highest TB burden countries [1] . Profound Vitamin D deficiency has been reported among new incident TB cases [2] and healthy volunteers in Pakistan [3] . Sufficient level of Vitamin D is important for macrophage activation for antimicrobial response [4] . The mechanism of activation of macrophages via Vitamin D pathway for anti-mycobacterial activity has already been delineated [5] . The stimulation of Toll like receptors (TLRs) on macrophages results in activation of Cathelicidin gene (hCAP18) by 1-hydroxylase enzyme gene (CYP27B1) [6] [7] and sepsis [8] . Cathelicidin family of peptides are 23-40 amino acid long chain with helical structure. Cathelicidin possess antimicrobial property because of its amphipathic topology and presence of negatively charged residue. Cathelicidin also up-regulates chemokine receptors on macrophages [9] and is involved in migration of immune cells to the site of infection.
Antimicrobial effect of Cathelicidin is very well studied against M. tuberculosis (M.tb) [10] . However, the anti-mycobacterial effect of Chemerin is not fully discovered. Chemerin is a non-glycosylated 16 kDa protein secreted as precursor of 143 amino acid residues known as Prochem 163S. This multifunctional protein primarily known for its adipokine and chemotactic activity for immune cells [Plasmacytoid (PDCs), NK and Macrophages)]. Proteolytic cleavage of pro-chemerin molecule by cathepsin results in formation of Chem 156 isoform which possess greater affinity for chemokine receptor like 1 (CMKLR1). Chemerin is structurally similar to N terminus Cathelin domain of human Cathelicidin. The predominant function of Chemerin is glucose homeostasis [11, 12] . Due to its involvement in regulation of immune cells and antimicrobial activity, it is intriguing to address the association of Chemerin with chronic inflammation such as TB. Its association in diabetes and obesity has already been established [13] . In countries with high burden of TB, the rate of pre-diabetes and Diabetes Mellitus (DM) is 24-25% among newly diagnosed TB patients [14] . Animal models of DM have also shown phenomenon of delayed inflammatory response in granuloma formation after aerosol challenge of M.tb [15, 16] . The relationship of low serum Vitamin D with incidence of DM [17] has significantly move the field to study the association of DM co-infected with TB [18, 19] . It is hypothesized that low serum Vitamin D may promote pro-inflammatory cytokines milieu which is favorable for progression of TB with or without comorbidity of DM. It is therefore interesting to understand the complex relationship of Chemerin (marker of obesity and Diabetes) with Cathelicidin and Vitamin D in TB patients. This relationship is described in a conceptual diagram in Fig. 1 .
The aim of our study is to assess the relationship of two related chemoattractant peptides, Cathelicidin and Chemerin with Vitamin D and pro-inflammatory cytokine (TNFα) in TB cases and healthy controls.
MATERIALS AND METHODS

Study Design
Twenty two (n=22) pulmonary TB patients (TB) were recruited from The Aga Khan University and Abbasi Shaheed Hospital outpatient clinics in this case control study. The chest physicians at both hospitals identified and referred the pulmonary TB patients as per study inclusion and exclusion criteria. Pulmonary disease was cytokines milieu which is favorable for progression of TB with or without comorbidity of DM. It is therefore interesting to understand the complex relationship of Chemerin (marker of h Cathelicidin and This relationship is described in a conceptual diagram in Fig. 1 .
The aim of our study is to assess the relationship of two related chemoattractant peptides, Cathelicidin and Chemerin with Vitamin D and nflammatory cytokine (TNFα) in TB cases
AND METHODS
Twenty two (n=22) pulmonary TB patients (TB) were recruited from The Aga Khan University Shaheed Hospital outpatient clinics se control study. The chest physicians at both hospitals identified and referred the pulmonary TB patients as per study inclusion and Pulmonary disease was confirmed by chest X-ray, Acid Fast Bacilli (AFB) sputum microscopy and history of TB symptoms. Majority of TB patients had moderate (PMD) (n=9) and, advanced (PAD) (n=7) pulmonary disease, two patients were characterized as minimal disease (PMD) and information was not available for 3 patients. The severity of disease classification was based on radiological findings, and extent of lung tissue involvement as per defined criteria [20] . Healthy endemic controls (EC; n=17) had no history of TB exposure and were recruited from administrative staff and research technologists of AKU research and teaching lab.
Study protocol was approved by Ethical Review Committee (ERC) of Aga Khan University ( Path-ERC-10). All participants gave written informed consent.
Inclusion criteria
The inclusion criteria for TB group (n=22) were active pulmonary TB diagnosed as per WHO guidelines [21] within one month of treatment. 
Exclusion criteria
Patients with treatment relapse or past TB history, extra-pulmonary TB and known MDR TB were not included in the study. TB patients with prior or current Vitamin D supplementation/injections, co-morbid conditions such as DM, malignancies or auto immune diseases were also excluded from the study.
Seventeen healthy controls were employees of AKU. The inclusion criteria for healthy controls (n=17) were no current or past TB diagnosis/DM/ chronic infections and no current or prior intervention with Vitamin D. Healthcare workers and lab staff directly exposed to TB were also excluded.
Collection of Blood for Plasma and Whole Blood Stimulation Assays
Five ml blood was collected in 15 ml of conical tube (BD Falcon) containing sodium heparin (20 U/ml; Leo Pharmaceuticals, Ballerup, Denmark). Heparinized blood was diluted 1:4 with RPMI 1640 (supplemented with Pen/Strep, 2 mM LGlutamine) for use in stimulation assays. Two ml of blood was collected separately in EDTA tube and centrifuged for 5 minutes at 2000 x g to separate clear portion i.e. plasma within 2hrs of collection. Plasma was stored in small aliquots and kept at -70ºC until further use.
Preparation of active vitamin D [1, 25-(OH) 2D3 ] for In vitro experiments
The 1, 25-(OH) 2 D3 Vitamin D was purchased from Sigma Chemicals (Sigma, St. Louis, USA). The crystallized form of Vitamin D was dissolved in reagent grade ethanol (EtOH) (Merck laboratories). A ten-fold higher working stock for each of the dilution was prepared to obtain a final concentration 0.1 µM in 500µl of whole blood cultures. Supernatants collected at day 1 and day 3 post stimulation were stored as 4 x 100 microliters aliquots in -80°C until use.
Assessment of cytokines (TNFα, IFN and IL10) in stimulated whole blood cultures and plasma
Cytokine assessment was carried out using pairs of monoclonal antibodies from Endogen, Rockford IL, USA. Protocols for cytokine assessment have been described in detail elsewhere [24] . Briefly, Immulon4 plates were coated with capture antibodies overnight at 4°C. Next day plates were blocked with BSA and subsequently incubated with 100 µl of culture supernatant. Revealing and probing antibodies were added after appropriate incubation. All probing antibodies were labeled with biotin and revealing antibodies were labeled with avidin bound to horse radish peroxidase (HRP). Finally plates were developed with HRP substrate. All plates were read on plate reader (Biorad, CA, USA). Optical densities were read against known concentration of standards (1000 pg-7.8 pg.) of cytokines to determine the concentrations in test samples [24] .
Estimation of inactive form of vitamin D [25(OH)D3] in plasma
Baseline Vitamin D levels were assessed in plasma samples of TB patients and healthy controls. Circulating Vitamin D was measured by ELISA using the Immuno Diagnostic System Ltd [IDS, Fountain Hill, AZ, USA]. All protocols were followed according to manufacturer instructions. Each test was run in duplicate, with mean absorbance of test samples computed from the average for two wells normalized for 0 calibrator well. Concentrations of Vitamin D in test samples were derived by fitting a 2 parameter logistic curve to 6 standard concentrations, and was expressed as ng/ml (1 nmol/L * 0.4= 1 ng/ml) [2] .
Estimation of Cathelicidin peptide by ELISA
Estimation of Cathelicidin peptide was carried out by ELISA (Hycult Biotechnology, AA Uden The Netherlands) assay in plasma samples. All protocols were followed according to manufacturer instructions. Each sample was run in duplicate. The minimum measurable concentration was between 0.1 ng/ml to up to 100 ng/ml of Cathelicidin. The unknown concentration was derived by plotting absorbance of samples against known concentrations of standards. All standard curve has R2 greater than 0.90.
Estimation of Chemerin peptide by ELISA
Chemerin levels in plasma samples were determined using a commercially available sandwich ELISA kit (Glory Bioscience, USA, cat #11406). The inter-assay coefficient of variation was less than 10%, and the within-assay coefficient of variation was less than 5%. The sensitivity of the ELISA assay was 0.5-10 ng/ml, and the midrange of the assay was 5 ng/ml. The least detectable concentration of human Chemerin was 0.5 ng/ml. 
Statistical Methods
RESULTS AND DISCUSSION
Characteristics of the Study Groups
TB group comprised of (54%) of male and (45%) female. The mean age of TB and EC groups were 25.136±8.697yrs (range 16-50yrs), and 31.647±5.219yrs (24-46yrs) respectively. BCG scar was present in 27% of TB patients and up to 90% in healthy controls. Overall incidence of HIV in TB cases is 0.96% in Pakistan [1]. TB patients were not screened for HIV positivity.
Relationship of circulating level of Cathelicidin, Chemerin and Vitamin D in TB and EC Group
The criteria for plasma Vitamin D [25(OH)D3] deficiency is based on international convention (reference plasma levels) (deficient = <20 ng/ml; insufficient =21-29 ng/ml; sufficient >30 ng/ml) [4] . A majority (71%; N= 28/39) of study participants had deficient Vitamin D levels [<20 ng/ml of plasma 25(OH) D3]. Fig. 2 shows the comparison of Chemerin (Fig.  2a) , Cathelicidin (Fig. 2b) Vitamin D (Fig. 2c) and TNFα (Fig. 2d) between TB and EC groups in box plots. In TB group, the level of Chemerin was significantly lower compared to controls (p=0.02). The average weight of TB patients was 41.22±3.77kg, and that of EC was 63.83±12.31 kg (T test; p=0.00004). The lower level of Chemerin in TB group is presumably due to lower body weight or less adipocytes.
We next compared the Cathelicidin and TNFα among TB and EC group, the level of Cathelicidin and TNFα are presumably higher in TB patients, although the medians are not significantly different. Cathelicidin and TNFα showed similar trends in box plots which were later confirmed by scatter plot that showed a linear relationship (Fig. 4) . There was no difference in Vitamin D level between TB and EC group.
In order to determine the pairwise comparison of biomarkers, we performed rank order analysis of whole study group to observe the trend of markers across the board. We next compared Cathelicidin and Chemerin levels in TB and EC groups. For this analysis, groups were divided in two categories of >median and ≤ median values of Cathelicidin ( Fig 3A) and Chemerin (Fig 3B) . 
Fig. 2. Distribution of antimicrobial peptide (cathelicidin), ad vitamin D and TNF
Box plot shows the serum level of Chemerin groups. The results are shown as median, 25 The estimation of Chemerin, Cathelicidin kits. Vitamin D was estimated by inhibition ELISA technique whe regular ELISA. TNFα detection was carried out by in antibodies. Mann Whitney U test was applied for comparison of significant difference in two groups. P<0.05 was
Fig. 3. Elevated level of
The bar graph shows the proportion of TB and EC group in two categories of > Cathelicidin (A) and Chemerin (B). X-axis sh Y-axis shows the % in each category. All test the proportion of subjects in two categories
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Distribution of antimicrobial peptide (cathelicidin), adipokine (chemerin), vitamin D and TNF in TB and EC groups
Chemerin(A), Cathelicidin(B), 25(OH)D3 (C), and TNFα (D) in TB and EC results are shown as median, 25 th and 75 th percentiles. Asterisks and circles are shown as outliers. Cathelicidin and vitamin D in blood was carried out by commercial sandwich ELISA D was estimated by inhibition ELISA technique where as Cathelicidin and Chemerin TNFα detection was carried out by in-house Sandwich ELISA using pairs of monoclonal U test was applied for comparison of significant difference in two groups. P<0.05 was considered significant
Elevated level of Cathelicidin but not Chemerin in TB patients
The bar graph shows the proportion of TB and EC group in two categories of >median and< median of axis shows the median categories of Cathelicidin and chemerinin ng/ml and All details of experiments are same as of Fig. 2. Median test was applied to test the proportion of subjects in two categories
ipokine (chemerin), (B), 25(OH)D3 (C), and TNFα (D) in TB and EC and circles are shown as outliers. and vitamin D in blood was
Correlation of Peptides (Cathelicidin and Chemerin) with Vitamin D and TNFα
ROC Analysis for Biomarker of TB
In order to assess the discriminatory power of markers in TB vs. EC groups, we carried out ROC analysis (Fig. 5) . In ROC analysis, Cathelicidin was identified as most discriminatory marker with AUC of 0.780 (p=0.007), followed by TNFα (AUC of 0.673 (p=0.097). Both Vitamin D and Chemerin had no discriminatory power. This further confirms no relationship of Cathelicidin and Chemerin in TB disease. High level of Cathelicidin in TB patient was also shown in Fig. 2 with marginal significance compared to EC group (p=0.06). Cathelicidin is also emerging as a marker of acute inflammation in TB patients, which was also confirmed by ROC analysis (Fig. 5 ).
To Fig. 1 ).
DISCUSSION
The current study was carried out to delineate the relationship of two chemotactic and antimicrobial peptides in TB and EC groups with similar level of Vitamin D deficiency.
Chemerin and Cathelicidin have structural homology at N terminus region of hCAP18 [25] . Both peptides are potent chemoattractant and possess antimicrobial activity against microbes [26] . The antibacterial activity was particularly exhibited by truncated peptides, Chem S 157 (truncated bioactive Chemerin lacking 6 amino acids) and S 155 against E. coli and K. pneumoniae [26] . These peptides also possess chemoattractant property for CMKLR1+ blood cells. Chemerin has been identified as a marker of pre-diabetic stage [27] , whereas Cathelicidin as a marker of acute inflammation and probable biomarker of TB [28] . Vitamin D deficiency is prevalent worldwide including Pakistan [2] . National Nutrition Survey of Pakistan 2011, reported a widespread deficiency of Vitamin D in both pregnant and non-pregnant women This deficiency was prevalent in both urban (87.9%) and rural (84.2%) women of child bearing age. Low serum Vitamin D was also correlated with Cathelicidin in sepsis patients and TB patients with smear positivity but over all vitamin D status [7] .
The increasing evidence of Vitamin D deficiency in both TB and diabetes has prompted us to investigate the actual relationship of markers of TB and Diabetes in context of Vitamin D. To our knowledge, this is the first study in Pa subjects delineating intricate relationship of Cathelicidin level with Chemerin in context of Vitamin D deficiency. The induction of Cathelicidin is dependent on sufficient level of active form of Vitamin D, which is also important for anti-mycobacterial activity of macrophages. However, our results showed no linear pregnant women [29] . This deficiency was prevalent in both urban (87.9%) and rural (84.2%) women of child g age. Low serum Vitamin D was also correlated with Cathelicidin in sepsis patients [8] and TB patients with smear positivity but not with (Fig. 4) . This was also confirmed by ROC analysis where Cathelicidin showed up as a single marker to discriminate TB group from healthy controls with 80% sensitivity and 40% specificity. Cathelicidin is also emerging as a new biomarker of TB disease [28 relationship of Cathelicidin with Vitamin D was also reported in TB patients, where high level of Cathelicidin was associated with high AFB positivity or disease severity [7] . was reported by Iacob et al. [30] in HCV infected patients. The other reports had conflicting results about correlation of Cathelicidin and Vitamin Din healthy controls [31, 32] . Dixon et al reported positive correlation between Cathelicidin and Vitamin D using <32 ng/ml cutoff in healthy controls. In contrast to this, another report showed a positive correlation with Vitamin D, and (Fig. 4) . This was also confirmed by ROC analysis where Cathelicidin showed up a single marker to discriminate TB group from healthy controls with 80% sensitivity and 40% specificity. Cathelicidin is also emerging as a [28] . A nonlinear relationship of Cathelicidin with Vitamin D was also reported in TB patients, where high level of Cathelicidin was associated with high AFB Similar finding in HCV infected The other reports had conflicting results about correlation of Cathelicidin and Vitamin Din Dixon et al reported positive correlation between Cathelicidin and Vitamin D using <32 ng/ml cutoff in healthy another report showed a positive correlation with Vitamin D, and To confirm the role of Cathelicidin as a marker of inflammation, we also looked at TNFα in both study groups (TB and EC), which showed a direct linear relationship with Cathelicidin (Fig. 4D ).
Due to the ubiquitous expression of Chemerin in inflammatory and metabolic pathway, its regulation is broadly classified as agonists for nuclear receptors, and immuno-modulators for chronic inflammation. The pathway of Chemerin release is meant to be regulated by Vitamin D receptor (VDR) [33] . An increase in expression of Chemerin mRNA was observed when adipocytes were treated with Vitamin D [34] . Furthermore, high level of circulating immune mediator such as Chemerin and VCAM are highly suggestive of inflammatory response in obese children with concurrent low vitamin D level [35] . results did not show such regulation of Chemerin and Vitamin D in our TB group, as both groups were deficient with Vitamin D but distribution of Chemerin was not homogenous in these groups. This relationship of Chemerin and Vitamin D holds true in case of inflammation of adipose [34] . Based on our results, we speculate that inflammatory response of Chemerin is primarily due to inflammation in adipose tissue which differs from chronic inflammation in TB patients as level of Chemerin are significantly lower in lean TB group.
In this study, we also studied the effect of exogenous addition of the active form of Vitamin D [1,25-(OH) 2 D3] in whole blood on the secretion of IFNand IL-10. Exogenous active form of Vitamin D stimulates anti-inflammatory cytokine (IL-10) and down regulates pro cytokine (IFN).
Since there was no difference in Vitamin D level, therefore TB and EC group were pooled for invitro experiment. In our in vitro experiments, we found an anti-inflammatory effect of 1,25 (OH) 2 D3, that enhances the secretion of IL while having a negative or no effect on IFNsecretion. Bioactive Vitamin D[1,25 D3] has immunosuppressive effect on var pro-inflammatory cytokines (IFN [22, 36] Based on our results, we speculate that inflammatory response of Chemerin is primarily due to inflammation in adipose tissue which differs from chronic inflammation in TB patients as level of Chemerin are significantly lower in lean TB group. this study, we also studied the effect of exogenous addition of the active form of Vitamin in whole blood on the secretion Exogenous active form of inflammatory cytokine 10) and down regulates pro-inflammatory Since there was no difference in Vitamin D level, therefore TB and EC group were pooled for experiments, we inflammatory effect of 1,25-D3, that enhances the secretion of IL-10, while having a negative or no effect on secretion. Bioactive Vitamin D[1,25-(OH) 2 D3] has immunosuppressive effect on various TNFα & IL12) ], and exerts its regulatory effect on T cells [37] .
The major limitation of our study was in accessibility of TB patient with co-morbid of Diabetes, which is critical to draw conclusion about role of Chemerin in TB with DM. 
CONCLUSION
Our results show a trend of nonlinear relationship of Cathelicidin and Chemerin in TB patients and healthy controls (EC) without comorbidity of DM. However, a linear relationship of Cathelicidin was observed with TNFα but not with Chemerin and Vitamin D. Cathelicidin was also identified as most discriminatory marker of inflammation in TB followed by TNFα. It is also important to study the relationship of these two peptides in TB patients with or without DM to further dissect the role of Chemerin and Cathelicidin in TB disease, and whether or not these markers can be used for screening TB with DM.
